NOVEL 3D MAPPING
SYSTEM REDUCED
PROCEDURE AND
FLUOROSCOPY TIME FOR
PERSISTENT ATRIAL
FIBRILLATION ABLATION

Navik 3D is a novel cardiac
mapping system that allows
localization of radiopaque
structures.
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BACKGROUND

Navik 3D is a novel mapping system that can locate radiopaque
objects including RF catheter and Cryoballoons in 3 dimensions.
Pulmonary vein isolation, roof line, and posterior wall
debulking can be performed using radiofrequency guided by
electroanatomic mapping (EAM), or cryoballooon guided by
Navik 3D, EAM, or both. We compared these approaches during
consecutive complex ablations for persistent atrial fibrillation.

DISCUSSION

Use of the cryoballoon aided by Navik
3D for additional lesions beyond
pulmonary vein isolation resulted in
lower fluoroscopy use and procedure
time for complex persistent AF cases.

 Recent literature has reported effectiveness of cryoballoon ablation
for isolation of the left atrial posterior wall and roofline.
 Navik 3D is the ONLY cardiac mapping system which allows the
user to locate any radiopaque object, including the cryoballoon, in 3D
(Figure 1) without limitations on catheter manufacturer.
 Navik 3D utilizes two views, for instance AP and LAO 20, to localize
the cryoballoon in a 3D map. Each localization requires 6 seconds of
fluoroscopy.
 In this retrospective study, using the Navik 3D mapping system
paired largely with the cryoballoon, we report shorter procedure time,
reduced fluoroscopy dose, and fluoroscopy time when compared with
electroanatomic mapping (EAM) or both Navik 3D combined with
EAM.
 This outcome might be due to the fact that cryoballoon lesions have a
much larger surface, rather than the point-by-point RF ablation
lesions.
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Figure 2: CTI = cavotricuspid isthmus. Other ablation = lesion(s) to eliminate signals in the
ganglionic plexi region of the left atrium, coronary sinus, or complex atrial electrograms in the left
atrium.
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pulmonary veins isolation (PVI) with cryoballoon ablation was
performed in all 57 patients with persistent atrial fibrillation.
Additional ablation lesions (posterior wall, roofline, or mitral
isthmus) were guided by [Navik 3D (n=16), EAM (n=15) or
both Navik 3D/EAM (n=26)], using [cryoballoon (n=18), RF
(n=15) or both (n=24)]. Groups were matched for age, sex,
prior ablation and antiarrhythmic use.
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CONCLUSION

Navik 3D resulted in lower procedure time and radiation dose
when used for complex ablations in persistent AF.

Figure 1: (A) AP view in Navik for cyro-ablation of PVI. (B) AP view in Navik for
cyro-ablation of PVI and roof line.
LSPV: left superior pulmonary vein, LIPV: left inferior pulmonary vein, RSPV: right
superior pulmonary vein. CS: coronary sinus, AP: anteroposterior
*Image taken from investigational APN Health Navik 3D device
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Figure 3: Percentage of each ablation method used with each mapping system.
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